Abstract:Gliomas take a number of different genetic routes in the progression to glioblastoma multiforme, a highly invasive variant that is mostly unresponsive to current therapies. The α‐chemokine stromal cell‐derived factor (SDF)‐1α binds to the seven transmembrane G‐protein‐coupled CXCR‐4 receptor and acts to modulate cell migration and proliferation by activating multiple signal transduction pathways. Leucine‐rich repeats containing 4 (LRRC4), a putative glioma suppressive gene, inhibits glioblastoma cells tumorigenesis in vivo and cell proliferation and invasion in vitro. We also previously demonstrated that LRRC4 controlled glioblastoma cells proliferation by ERK/AKT/NF‐κB signaling pathway. In the present study, we demonstrate that CXC chemokine receptor 4 (CXCR4) is expressed in human glioblastoma U251 cell line, and that SDF‐1α increases the proliferation, chemotaxis, and invasion in CXCR4+ glioblastoma U251 cells through the activation of ERK1/2 and Akt. The reintroduction of LRRC4 in U251 cells inhibits the expression of CXCR4 and SDF‐1α/CXCR4 axis‐mediated downstream intracellular pathways such as ERK1/2 and Akt leading to proliferate, chemotactic and invasive effects. Furthermore, we provide evidence for proMMP‐2 activation involvement in the SDF‐1α/CXCR4 axis‐mediated signaling pathway. LRRC4 significantly inhibits proMMP‐2 activation by SDF‐1α/CXCR4 axis‐mediated ERK1/2 and Akt signaling pathway. Collectively, these results suggest a possible important “cross‐talk” between LRRC4 and SDF‐1α/CXCR4 axis‐mediated intracellular pathways that can link signals of cell proliferation, chemotaxis and invasion in glioblastoma, and may represent a new target for development of new therapeutic strategies in glioma. J. Cell. Biochem. 103: 245–255, 2008. © 2007 Wiley‐Liss, Inc.

Profiling of Differentially Expressed Genes in LRRC4 Overexpressed Glioblastoma Cells by Cdna Array

Progress in LRRC4, a Novel Brain-specific Gene/Glioma Suppressive Gene

Comparative Proteomics Analysis of Differentially Expressed Proteins in U251 Cells Transfected by pcDNA3.1(+) or LRRC4 Gene

Expression and Functional Characterization of LRRC4, a Novel Brain‐specific Member of the LRR Superfamily

Expression of LRRC4 Has the Potential to Decrease the Growth Rate and Tumorigenesis of Glioblastoma Cell Line U251.

Study of a novel brain relatively specific gene LRRC4 involved in glioma tumorigenesis suppression using the Tet-on system.

Function of a Novel Brain-Specific Gene LRRC4

Establishment Of Brain Relatively Specific Gene Lrrc4 With Doxycycline Induced Tet Regulating System In U251 Glioblatoma Cell Line

Suppression of Growth and Invasion Phenotypes in Glioblastoma U251 Cells by LRR Domain of LRRC4

LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.

Suppression Of Growth And Invasion Phenotypes In Glioblastoma U251 Cells By The Lrr Domain Of Lrrc4

LRRC4, a Putative Tumor Suppressor Gene, Requires a Functional Leucine-Rich Repeat Cassette Domain to Inhibit Proliferation of Glioma Cells in Vitro by Modulating the Extracellular Signal-Regulated Kinase/protein Kinase B/nuclear Factor-Kappab Pathway.

Expression Absence of LRRC4 Gene in Glioblastoma Cell Lines

Lrrc4 Inhibits Mobility And Invasion Through The Sdf-1a/Cxcr4 Axis In U251 Cells

LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.

Blockage of U251 Cells in G0/G1 Through MAPK Signaling Pathway by LRRC4

Promoter Hypermethylation-mediated Inactivation of LRRC4 in Gliomas

LRRC4 Controls in Vitro Invasion of Glioblastoma Cells Through Inhibiting RPTP-zeta Expression.

LRRC4 inhibits the proliferation of human glioma cells by modulating the expression of STMN1 and microtubule polymerization.

Leucine-rich Repeat C4 Protein is Involved in Nervous Tissue Development and Neurite Outgrowth, and Induction of Glioma Cell Differentiation.

LRRC4 Inhibits Human Glioblastoma Cells Proliferation, Invasion, and Prommp‐2 Activation by Reducing SDF‐1α/CXCR4‐mediated ERK1/2 and Akt Signaling Pathways